Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Diagnostic Tests for Acute Rhinosinusitis Infections Reviewed

By LabMedica International staff writers
Posted on 28 Oct 2016
Acute rhinosinusitis (ARS) is defined as inflammation of the paranasal sinuses caused by viral or bacterial infection, and typically presents with facial pain or pressure, purulent nasal discharge, fever, cacosmia or hyposmia, and double sickening.

Many patients who see physicians for sinus infections expect to be prescribed an antibiotic, but for the majority of them, that course of treatment will not be effective. Unfortunately, there are not great diagnostic tools to determine which patients will or will not benefit from antibiotics.

Medical scientists at the University of Georgia (Athens, GA, USA) analyzed 30 studies of outpatients with a respiratory tract infection to see which diagnostic criteria, if any, were most accurate for diagnosing sinus infection. These included studies of adults and children with clinically suspected sinusitis or acute respiratory tract infection that reported the accuracy of at least one blood test or imaging study for ARS or acute bacterial rhinosinusitis (ABRS). Acceptable reference standards included radiography, ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) for ARS, and antral puncture revealing purulent fluid or fluid yielding a positive culture for ABRS.

Blood tests studied included C-reactive protein (CRP), white blood cell count (WBC), and the erythrocyte sedimentation rate (ESR), and other tests included rhinoscopy, a test of nasal secretions, and the accuracy of scintigraphy. An ESR of greater than 10 is limited evidence against a diagnosis of acute rhinosinusitis, while an ESR of greater than 30 or 40 provide moderate evidence in favor of the diagnosis. Similarly, a CRP of less than 10 mg/L was limited evidence against a diagnosis of ARS while a CRP of greater than 20 mg/L is limited evidence in favor of the diagnosis. Only one of the four studies of CRP used antral puncture as the reference standard, and it had generally similar results to the imaging studies.

The authors concluded that in general, tests were of limited value in the diagnosis of ARS. Normal radiography helps rule out sinusitis when negative, whereas CRP and ESR help rule in sinusitis when positive, although, given their limited accuracy as individual tests, they cannot be routinely recommended. Prospective studies integrating signs and symptoms with point-of-care CRP, dipstick, and/ or handheld B-mode ultrasound are needed.

Mark H. Ebell, MD, a professor and lead author of the study said, “The use of C-reactive protein is promising as a point of care test to reduce the overuse of antibiotics. There have been several studies in Europe showing that in the primary care setting, having the CRP results that show a patient is unlikely to have bacterial sinusitis, doctors are more confident about not using antibiotics and they've reduced inappropriate antibiotics use.” The study was published on September 1, 2016, in the British Journal of General Practice.

Related Links:
University of Georgia


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Centromere B Assay
Centromere B Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.